Pancreatic Cancer Research

ResearcherNanjing University of Chinese MedicineActive in the last 2 years

Yingying Cao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2812-2299; OpenAlex author ID A5035344575, A5109000140. Sources: OpenAlex.

Their work

Papers
12 (first author 3, last author 1)
Trials
0
Grants
0
Labs led
1
Collaborators
25
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 3 papers · 2024: 2 papers · 2025: 4 papers · 2026: 1 paper

Papers 12

  1. Diagnostic performance of multislice spiral computed tomography in differentiating pancreatic acinar cell carcinoma from pancreatic ductal adenocarcinoma. First author DOI 10.1007/s00261-026-05617-8↗
  2. Segment Like A Doctor: Learning reliable clinical thinking and experience for pancreas and pancreatic cancer segmentation. First author DOI 10.1016/j.media.2025.103539↗
  3. Serum High-Density Lipoprotein Cholesterol Concentrations in Pancreatic Ductal Adenocarcinoma and Its Association With Histological Grade in a Chinese Populati… Co-author DOI 10.1177/10732748251316602↗
  4. Serum exosomal hsa-let-7f-5p: A potential diagnostic biomarker for metastatic pancreatic cancer detection. Last author DOI 10.3748/wjg.v31.i26.109500↗
  5. Diagnostic Value of Serum D-dimer, CA19-9, and CT Imaging Features in Pancreatic Ductal Adenocarcinoma and Benign Pancreatic Lesions. First author DOI 10.7150/jca.111548↗
  6. Computed tomography-based radiomics diagnostic approach for differential diagnosis between early- and late-stage pancreatic ductal adenocarcinoma. Co-author DOI 10.4251/wjgo.v16.i4.1256↗
  7. Comparison between solid pseudopapillary neoplasms of the pancreas and pancreatic ductal adenocarcinoma with cystic changes using computed tomography. Co-author DOI 10.4329/wjr.v16.i6.211↗
  8. Biomarkers for pancreatic cancer based on tissue and serum metabolomics analysis in a multicenter study. Co-author DOI 10.1002/cam4.5296↗
  9. Untargeted metabolomics characterization of the resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.1177/20552076231179007↗
  10. Exploring the key genetic association between chronic pancreatitis and pancreatic ductal adenocarcinoma through integrated bioinformatics. Co-author DOI 10.3389/fgene.2023.1115660↗
  11. Potential Metabolite Biomarkers for Early Detection of Stage-I Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fonc.2021.744667↗
  12. Computed Tomography-Based Radiomics Signature for the Preoperative Differentiation of Pancreatic Adenosquamous Carcinoma From Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fonc.2020.01618↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shuai Ren · 10 shared papers, 2020–2026 · strength 2.12
  2. Zhongqiu Wang · 8 shared papers, 2020–2025 · strength 1.52
  3. Kai Guo · 6 shared papers, 2020–2025 · strength 1.04
  4. Rui Zhao · 5 shared papers, 2020–2025 · strength 0.92
  5. Yuan Li · 2 shared papers, 2025 · strength 0.55
  6. Zipeng Lu · 3 shared papers, 2021–2023 · strength 0.48
  7. Ying Tian · 2 shared papers, 2024 · strength 0.47
  8. Yuan Li · 2 shared papers, 2023 · strength 0.36
  9. Zi Wang · 1 shared paper, 2026 · strength 0.33
  10. Fan Xia · 1 shared paper, 2026 · strength 0.33
  11. Jie Yu · 1 shared paper, 2026 · strength 0.33
  12. Qi Lan · 1 shared paper, 2026 · strength 0.33
  13. Shuai Ren · 1 shared paper, 2025 · strength 0.33
  14. Xiaoping Yang · 1 shared paper, 2025 · strength 0.28
  15. Zhenghua Cai · 1 shared paper, 2025 · strength 0.28
  16. Liwen Zou · 1 shared paper, 2025 · strength 0.28
  17. Yudong Qiu · 1 shared paper, 2025 · strength 0.28
  18. Lina Song · 1 shared paper, 2023 · strength 0.18
  19. Jian He · 1 shared paper, 2023 · strength 0.17
  20. Kai Zhang · 1 shared paper, 2023 · strength 0.17
  21. Donghui Li · 1 shared paper, 2023 · strength 0.17
  22. Tao Li · 1 shared paper, 2021 · strength 0.13
  23. Xiao Chen · 1 shared paper, 2021 · strength 0.13
  24. Wenli Qiu · 1 shared paper, 2020 · strength 0.11
  25. Rong Chen · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.